全球 CRISPR 技術市場規模、佔有率、趨勢和成長分析報告（2026-2034 年）

CRISPR 技術市場預計將從 2025 年的 73.4 億美元成長到 2034 年的 297.8 億美元，2026 年至 2034 年的複合年成長率為 16.84%。

受基因編輯技術和生物技術研究進展的推動，全球CRISPR技術市場正快速成長。 CRISPR系統能夠實現精準的基因修飾，支持在治療方法、農業和生物醫學研究等領域的應用。基因組學和個人化醫療領域投資的增加正在加速市場擴張。

關鍵成長要素包括研究經費的增加、基因治療需求的成長以及基因編輯精度和效率的技術進步。製藥公司正在積極探索基於CRISPR技術的遺傳疾病和癌症治療方法。然而，倫理問題和監管方面的複雜性仍然是重要的考量。

展望未來，基因編輯療法的持續臨床試驗和商業化將塑造市場發展。農業生物技術領域應用的拓展以及合作研究舉措將進一步推動市場成長。隨著法規結構的完善，CRISPR技術有望在醫學和生命科學領域發揮變革性作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球CRISPR技術市場：依產品與服務分類

• 市場分析、洞察與預測
• 產品
• 服務

第5章全球CRISPR 技術市場：按應用分類

• 市場分析、洞察與預測
• 藥物發現與開發
• 農業
• 其他用途

第6章 全球CRISPR技術市場：依最終使用者分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 學術研究機構
• 其他（CRO 和 CDMO）

第7章 全球CRISPR技術市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Agilent Technologies Inc
  • Genscript Biotech Corporation
  • CRISPR Therapeutics AG
  • Editas Medicine
  • Intellia Therapeutics Inc
  • Beam Therapeutics Inc
  • Caribou Biosciences Inc
  • Lonza Group Ltd
  • Danaher Corporation

The CRISPR Technology Market size is expected to reach USD 29.78 Billion in 2034 from USD 7.34 Billion (2025) growing at a CAGR of 16.84% during 2026-2034.

The global CRISPR technology market is growing rapidly due to advancements in gene editing and biotechnology research. CRISPR systems enable precise genetic modifications, supporting applications in therapeutics, agriculture, and biomedical research. Increasing investment in genomics and personalized medicine is accelerating market expansion.

Key drivers include rising research funding, growing demand for gene-based therapies, and technological improvements in editing accuracy and efficiency. Pharmaceutical companies are actively exploring CRISPR-based treatments for genetic disorders and cancer. However, ethical concerns and regulatory complexities remain important considerations.

Looking forward, continued clinical trials and commercialization of gene-editing therapies will shape market evolution. Expanding agricultural biotechnology applications and collaborative research initiatives will further support growth. As regulatory frameworks mature, CRISPR technology is expected to play a transformative role in medicine and life sciences.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Services

• Products
• Services

By Application

• Drug Discovery & Development
• Agriculture
• Other Applications

By End User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others (CROs & CDMOs)

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Merck KGaA, Agilent Technologies Inc, Genscript Biotech Corporation, CRISPR Therapeutics AG, Editas Medicine, Intellia Therapeutics Inc, Beam Therapeutics Inc, Caribou Biosciences Inc, Lonza Group Ltd, Danaher Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CRISPR TECHNOLOGY MARKET: BY PRODUCT & SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Services
• 4.2. Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CRISPR TECHNOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Agriculture Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CRISPR TECHNOLOGY MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others (CROs & CDMOs) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CRISPR TECHNOLOGY MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product & Services
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product & Services
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product & Services
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product & Services
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product & Services
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CRISPR TECHNOLOGY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Merck KGaA
  • 9.2.3 Agilent Technologies Inc
  • 9.2.4 Genscript Biotech Corporation
  • 9.2.5 CRISPR Therapeutics AG
  • 9.2.6 Editas Medicine
  • 9.2.7 Intellia Therapeutics Inc
  • 9.2.8 Beam Therapeutics Inc
  • 9.2.9 Caribou Biosciences Inc
  • 9.2.10 Lonza Group Ltd
  • 9.2.11 Danaher Corporation